Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Fresenius Medical Care Partners with JMS Co. Ltd. to Advance Home Dialysis Treatment in Japan

09/17/2021 | 03:12am EDT

Fresenius Medical Care has announced a strategic distribution partnership with JMS Co. Ltd. Under the agreement, JMS Co. Ltd. will distribute Fresenius Medical Care’s innovative home dialysis therapies in the Japanese market, providing patients with a wider range of dialysis choices to suit their lifestyle, enhance their wellbeing, and to help address the home healthcare needs of Japan’s aging population. Under the agreement, JMS Co. Ltd. will distribute the advanced portfolio of Fresenius Medical Care’s home dialysis systems in Japan, including automatic peritoneal dialysis system. These systems, which have US Federal Drug Authority (FDA) and European CE Mark approvals, are used widely in other developed countries.


© S&P Capital IQ 2021
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
05:34aFRESENIUS MEDICAL CARE : further enhances clinical care through continuous digital quality..
PU
10/22FMC FRESENIUS MEDICAL CARE AG & CO K : JP Morgan maintains a Sell rating
MD
10/21FMC FRESENIUS MEDICAL CARE AG & CO K : Barclays reaffirms its Neutral rating
MD
10/18European ADRs Move Lower in Monday Trading
MT
10/07FMC FRESENIUS MEDICAL CARE AG & CO K : Jefferies maintains a Sell rating
MD
10/07FMC FRESENIUS MEDICAL CARE AG & CO K : NorldLB reiterates its Buy rating
MD
10/07Fresenius Medical Care AG & Co. KGaA acquired Sugerencias Medicas S.A.
CI
10/05FRESENIUS MEDICAL CARE : donates 250,000 euros to UNICEF - battle against COVID-19 pandemi..
AQ
10/05FMC FRESENIUS MEDICAL CARE AG & CO K : Barclays reiterates its Neutral rating
MD
09/30FRESENIUS SE & CO. KGAA : Release according to Article 41 of the WpHG [the German Securiti..
DJ
More news
Analyst Recommendations on FRESENIUS MEDICAL CARE AG & CO. KGAA
More recommendations
Financials (USD)
Sales 2021 21 089 M - -
Net income 2021 1 271 M - -
Net Debt 2021 13 395 M - -
P/E ratio 2021 16,3x
Yield 2021 1,95%
Capitalization 21 050 M 21 061 M -
EV / Sales 2021 1,63x
EV / Sales 2022 1,53x
Nbr of Employees 123 538
Free-Float 67,8%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 19
Last Close Price 71,85 $
Average target price 80,87 $
Spread / Average Target 12,6%
EPS Revisions
Managers and Directors
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer